skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

Appendix A: Pediatric Antiretroviral Drug Information

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)
Abacavir (ABC, Ziagen) 
Didanosine (ddI, Videx) 
Emtricitabine (FTC, Emtriva) 
Lamivudine (3TC/Epivir) 
Stavudine (d4T, Zerit) 
Tenofovir Disoproxil Fumarate (TDF, Viread) 
Zidovudine (ZDV, AZT, Retrovir) 

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)
Efavirenz (EFV, Sustiva) 
Etravirine (ETR, Intelence, TMC 125) 
Nevirapine (NVP, Viramune)
Rilpivirine (RPV, Edurant, TMC 278)

Protease Inhibitors (PIs)
Atazanavir (ATV, Reyataz) 
Darunavir (DRV, Prezista) 
Fosamprenavir (FPV, Lexiva) 
Indinavir (IDV, Crixivan) 
Lopinavir/Ritonavir (LPV/r, Kaletra) 
Nelfinavir (NFV, Viracept) 
Ritonavir (RTV, Norvir) 
Saquinavir (SQV, Invirase) 
Tipranavir (TPV, Aptivus) 

Entry and Fusion Inhibitors
Enfuvirtide (ENF, T-20, Fuzeon) 
Maraviroc (MVC, Selzentry) 

Integrase Inhibitors
Dolutegravir (DTG)
Elvitegravir (EVG)
Raltegravir (RAL, Isentress)